RENEW Intervention for Axial Spondyloarthritis
Pilot Randomized Controlled Trial of the RENEW Intervention for Axial Spondyloarthritis
1 other identifier
interventional
40
1 country
1
Brief Summary
The researchers are testing a web-based peer-led program to help manage energy and symptoms in people who have axial spondyloarthritis (axSpA). There are 3 main reasons the researchers are doing this study: 1) to test how easy it is for people with spondyloarthritis to use the RENEW program; 2) to assess whether people like the RENEW program and 3) to understand if it helps with symptom management and disease burden.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2026
CompletedFirst Submitted
Initial submission to the registry
September 17, 2026
CompletedFirst Posted
Study publicly available on registry
September 23, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2027
September 23, 2026
September 1, 2026
6 months
September 17, 2026
September 17, 2026
Conditions
Outcome Measures
Primary Outcomes (4)
attendance at peer health coaching sessions among RENEW intervention participants.
Assessed using the Goal Attainment Scaling (GAS) method, which measures the extent to which participants achieved their individualized goals
across the 12-week period
Goal Attainment Scaling (GAS)
Assessed by health coach
Weeks 0, 6, 12
Theoretical Framework of Acceptability (TFA) score (RENEW Intervention group)
12-item measure assessing affective attitude, burden, perceived effectiveness, and self-efficacy. An average of item scores \>4 out of 5 has been established as indicating high acceptability.
Week 12
Qualitative Interviews (n=10-15 of RENEW Intervention group)
Acceptability will also be assessed through qualitative interviews with a subset of intervention participants.
Week 12
Study Arms (2)
Group 1: RENEW Program
EXPERIMENTALParticipants placed in this group will be assigned a peer health coach to help guide them through the RENEW program right away. Peer health coaches are people on the study team with spondyloarthritis. In addition, approximately 10 to 15 people from this group will be invited to take part in an optional 30-minute interview after the program ends, to share feedback about their experience with RENEW. If invited, participating in this interview is entirely voluntary.
Group 2: Waitlist Group
NO INTERVENTIONIf placed in this group, participants will receive access to the RENEW website at the end of the 12-week study period. At the end of the 12 weeks, participants will be offered the option to have 1 peer health coaching session with a peer health coach.
Interventions
RENEW is a 12-week, peer-led, web-based program to help people with spondyloarthritis learn skills that can be used to manage disease symptoms and improve well-being. It includes: A website that includes information, worksheets, tools, and information from other people with spondyloarthritis 9 calls with a peer health coach, beginning with weekly calls for the first 6 weeks, and every other week for the last 6 weeks of the program. We will use telehealth platforms (like Zoom) for these calls. We will record them so we can track how well the peer health coaches are following the program. Each call will last no more than 30 minutes.
Eligibility Criteria
You may qualify if:
- Physician-diagnosed axSpA (including non-radiographic axSpA)
- Have moderate to severe fatigue (average of ≥4/7 on the Fatigue Severity Scale)
- Access to a computer, tablet, or smartphone with internet connection
- Ability to speak and read English
- Willingness to participate in virtual Zoom coaching sessions and complete online assessments
- Interested in making some changes and trying new ways to improve health and well-being
You may not qualify if:
- Currently enrolled in other clinical trials
- Currently undergoing structured rehabilitation or psychological treatment for major depressive disorder
- Significant cognitive impairment that would prevent informed consent or participation
- Severe psychiatric illness that would contraindicate participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Michiganlead
- Spondyloarthritis Association of Americacollaborator
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susan Murphy, ScD, OTR
University of Michigan
- PRINCIPAL INVESTIGATOR
Yen Chen, PhD
University of Michigan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 17, 2026
First Posted
September 23, 2026
Study Start
September 1, 2026
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
May 1, 2027
Last Updated
September 23, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share